Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix Post-Marketing Safety Study in Chinese Adults ≥50 Years
CTR20201049Phase 4Completed
- Sponsor
- ---
- Start
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by ---. Started Jun 2020; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20201049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201049.